131 related articles for article (PubMed ID: 33064241)
1. Digoxin use is associated with pancreatic cancer risk but does not affect survival.
Boursi B; Huber JS; Haynes K; Mamtani R; Yang YX
Cancer Causes Control; 2021 Jan; 32(1):41-46. PubMed ID: 33064241
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors on pancreatic cancer risk and survival.
Kearns MD; Boursi B; Yang YX
Cancer Epidemiol; 2017 Feb; 46():80-84. PubMed ID: 28056391
[TBL] [Abstract][Full Text] [Related]
3. Digoxin use and the risk for colorectal cancer.
Boursi B; Haynes K; Mamtani R; Yang YX
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1147-53. PubMed ID: 25263572
[TBL] [Abstract][Full Text] [Related]
4. Ion channel blockers and glioblastoma risk and outcome: a nested case-control and retrospective cohort studies.
Boursi B; Han HJ; Haynes K; Mamtani R; Yang YX
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1179-1185. PubMed ID: 27384764
[TBL] [Abstract][Full Text] [Related]
5. The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer.
Mandilaras V; Bouganim N; Yin H; Asselah J; Azoulay L
Br J Cancer; 2017 Jan; 116(1):103-108. PubMed ID: 27846200
[TBL] [Abstract][Full Text] [Related]
6. Total Serum Cholesterol and Pancreatic Cancer: A Nested Case-Control Study.
Chen WC; Boursi B; Mamtani R; Yang YX
Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):363-369. PubMed ID: 30333217
[TBL] [Abstract][Full Text] [Related]
7. Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.
Azoulay L; Filion KB; Platt RW; Dahl M; Dormuth CR; Clemens KK; Durand M; Juurlink DN; Targownik LE; Turin TC; Paterson JM; Ernst P;
BMJ; 2016 Feb; 352():i581. PubMed ID: 26888382
[TBL] [Abstract][Full Text] [Related]
8. Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study.
Saad A; Goldstein J; Margalit O; Shacham-Shmueli E; Lawrence YR; Yang YX; Reiss KA; Golan T; Mamtani R; Halpern N; Aderka D; Mouallem M; Goldstein A; Giantonio B; Boursi B
Pharmacoepidemiol Drug Saf; 2020 May; 29(5):599-604. PubMed ID: 32196836
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study.
Bradley MC; Hughes CM; Cantwell MM; Napolitano G; Murray LJ
Br J Cancer; 2010 Apr; 102(9):1415-21. PubMed ID: 20372155
[TBL] [Abstract][Full Text] [Related]
10. Use of incretin agents and risk of pancreatic cancer: a population-based cohort study.
Knapen LM; van Dalem J; Keulemans YC; van Erp NP; Bazelier MT; De Bruin ML; Leufkens HG; Croes S; Neef C; de Vries F; Driessen JH
Diabetes Obes Metab; 2016 Mar; 18(3):258-65. PubMed ID: 26537555
[TBL] [Abstract][Full Text] [Related]
11. Recurrent antibiotic exposure may promote cancer formation--Another step in understanding the role of the human microbiota?
Boursi B; Mamtani R; Haynes K; Yang YX
Eur J Cancer; 2015 Nov; 51(17):2655-64. PubMed ID: 26338196
[TBL] [Abstract][Full Text] [Related]
12. Duration of diabetes and pancreatic cancer in a case-control study in the Midwest and the Iowa Women's Health Study (IWHS) cohort.
Henry SA; Prizment AE; Anderson KE
JOP; 2013 May; 14(3):243-9. PubMed ID: 23669472
[TBL] [Abstract][Full Text] [Related]
13. The differential effects of statins on the risk of developing pancreatic cancer: a case-control study in two centres in the United Kingdom.
Carey FJ; Little MW; Pugh TF; Ndokera R; Ing H; Clark A; Dennison A; Metcalfe MS; Robinson RJ; Hart AR
Dig Dis Sci; 2013 Nov; 58(11):3308-12. PubMed ID: 23864194
[TBL] [Abstract][Full Text] [Related]
14. Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk.
Boursi B; Haynes K; Mamtani R; Yang YX
J Natl Cancer Inst; 2015 Jun; 107(6):djv084. PubMed ID: 25855726
[TBL] [Abstract][Full Text] [Related]
15. Use of antidepressants and risk of lung cancer.
Toh S; Rodríguez LA; Hernández-Díaz S
Cancer Causes Control; 2007 Dec; 18(10):1055-64. PubMed ID: 17682831
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of pernicious anemia and the risk of pancreatic cancer.
Shah P; Rhim AD; Haynes K; Hwang WT; Yang YX
Pancreas; 2014 Apr; 43(3):422-6. PubMed ID: 24622073
[TBL] [Abstract][Full Text] [Related]
17. Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts.
Stolzenberg-Solomon RZ; Newton CC; Silverman DT; Pollak M; Nogueira LM; Weinstein SJ; Albanes D; Männistö S; Jacobs EJ
Am J Epidemiol; 2015 Aug; 182(3):187-97. PubMed ID: 26085045
[TBL] [Abstract][Full Text] [Related]
18. The Association between Age-Related Macular Degeneration and Renal Cell Carcinoma: A Nested Case-Control Study.
Keizman D; Yang YX; Gottfried M; Dresler H; Leibovitch I; Haynes K; Mamtani R; Boursi B
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):743-747. PubMed ID: 28062400
[No Abstract] [Full Text] [Related]
19. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.
Bruderer SG; Bodmer M; Jick SS; Bader G; Schlienger RG; Meier CR
Diabetes Obes Metab; 2014 Sep; 16(9):801-11. PubMed ID: 24612200
[TBL] [Abstract][Full Text] [Related]
20. Posttraumatic Stress Disorder and Cancer Risk: A Nested Case-Control Study.
Cohn E; Lurie I; Yang YX; Bilker WB; Haynes K; Mamtani R; Shacham-Shmueli E; Margalit O; Boursi B
J Trauma Stress; 2018 Dec; 31(6):919-926. PubMed ID: 30520529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
